SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

BULL NASDAQ is trending due to significant selling pressure, widely attributed to year-end tax-loss harvesting and ongoing dilution from its SPAC structure. Community sentiment is deeply divided, with optimists pointing to Webull's strong profitability, user growth, and international expansion as a long-term opportunity, while frustrated bears highlight continuous price declines and question its ability to compete in the fintech brokerage sector.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following the FDA approval of tradipitant for motion sickness, marking the first new treatment in decades. This milestone, combined with promising Phase 2 data showing tradipitant's efficacy in reducing GLP-1 induced nausea and vomiting, has ignited widespread community discussion about its significant potential in a rapidly expanding market. Investors are also keenly anticipating upcoming regulatory decisions for other pipeline candidates, fueling speculation about substantial growth and future acquisition interest.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group Inc. is actively trending as its stock recently hit new all-time lows, sparking widespread concern and disappointment among investors regarding management's leadership and the company's financial trajectory. The community is intensely debating potential missed production targets, the ongoing interim CEO situation, and fears of further dilution or a reverse stock split amidst a challenging luxury EV market and comparisons to competing EV manufacturers.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amid speculation surrounding the FDA approval of Novo Nordisk's oral Wegovy pill, with the community actively discussing potential partnerships that could impact the burgeoning GLP-1 market. While many investors express frustration over the stock's recent decline and high short interest, others see current price levels as a significant long-term buying opportunity, emphasizing the company's continuous expansion into new healthcare verticals and robust fundamentals.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is a major talking point as its repeatedly delayed proxy vote on increasing authorized shares fuels investor anxiety, with many debating if it signals essential growth capital or future dilution. The community is buzzing with speculation about impending government AI and defense contracts, including potential classified work and the integration of strategic acquisitions like Ask Sage. This creates a highly polarized environment, where optimism for the company's long-term defense sector role clashes with concerns over near-term execution and market uncertainty.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is a hot topic as investors intensely debate its recent price volatility, with many attributing the decline to year-end tax loss selling ahead of CES 2026. Bulls are accumulating shares, confident in its strong revenue growth, substantial contractual backlog, and leading voice and agentic AI technology for sectors like automotive and restaurants. Conversely, a vocal group expresses deep concern over significant insider selling and the stock's pronounced drawdown, leading to a sharply divided outlook on its immediate future performance.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is capturing significant attention with strong upward momentum, fueled by expanding market access through new perpetual listings and a series of sustained price advancements. The community is buzzing with comparisons to prominent meme coins, envisioning $YEE as a leading narrative within the 'ETH season,' sustained by a deeply committed and unified holder base.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

SCLX is trending amidst recent financial maneuvers, including a significant loan collateralized by Datavault AI shares and a highly anticipated 'meme coin' dividend. The community is sharply divided; optimists believe these are strategic moves by CEO Henry Ji to trigger a short squeeze and unlock vast future value from AI licensing, while critics view them as desperate tactics leading to further dilution and eventual collapse, drawing comparisons to past ventures.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is generating significant buzz as its community intensely debates potential price movements leading into the new year. Many anticipate a strong rebound following the conclusion of year-end tax loss selling, with hopes for upward momentum. Conversely, a vocal segment expresses bearish sentiment, warning of further declines and questioning its long-term viability within the meme coin sector.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is trending as investors anticipate a major mortgage refinancing wave, driven by expectations of future rate cuts and bullish technical indicators. The community is actively discussing RKT's strategic evolution into a comprehensive housing and fintech platform, with significant institutional interest suggesting a potential re-rating and sustained upside through 2026.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Medical Stocks Lagging  Compass Therapeutics, Inc. (CMPX) This Year?

Here is how Compass Therapeutics, Inc. (CMPX) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

Wall Street Analysts Think Compass Therapeutics, Inc. (CMPX) Could Surge 134.14%: Read This Before Placing a Bet

The consensus price target hints at a 134.1% upside potential for Compass Therapeutics, Inc. (CMPX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Vivo Capital LLC Purchases 2,487,443 Shares of Compass Therapeutics, Inc. $CMPX

Vivo Capital LLC increased its position in shares of Compass Therapeutics, Inc. (NASDAQ:CMPX - Free Report) by 70.0% in the second quarter, according to its most recent disclosure with the Securities...

Here's Why Compass Therapeutics, Inc. (CMPX) is a Great Momentum Stock to Buy

Does Compass Therapeutics, Inc. (CMPX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of "Moderate Buy" from Analysts

Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) has received a consensus rating of "Moderate Buy" from the fifteen analysts that are currently covering the stock, Marketbeat.com reports...

Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated at Citizens Jmp

Citizens Jmp assumed coverage on Compass Therapeutics in a research report on Wednesday. They issued an "outperform" rating and a $10.00 price target for the company...

Compass Therapeutics (NASDAQ:CMPX) Now Covered by Analysts at Canaccord Genuity Group

Canaccord Genuity Group started coverage on shares of Compass Therapeutics in a research note on Wednesday. They set a "buy" rating and a $10.00 price target on the stock...

Compass Therapeutics (NASDAQ:CMPX) Trading Down 6% - Time to Sell?

Compass Therapeutics (NASDAQ:CMPX) Trading Down 6% - Time to Sell...

Compass Therapeutics (NASDAQ:CMPX) Sets New 52-Week High - Time to Buy?

Compass Therapeutics (NASDAQ:CMPX) Reaches New 1-Year High - Here's What Happened...

Analysts Issue Forecasts for CMPX FY2025 Earnings

Compass Therapeutics, Inc. (NASDAQ:CMPX - Free Report) - Leerink Partnrs issued their FY2025 earnings per share (EPS) estimates for shares of Compass Therapeutics in a research note issued to...

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

CMPX
Compass Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CMPX News

CMPXCompass Therapeutics Inc